Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration
Phase 1 Pilot Open Label Prospective Observational Study of Safety and Tolerability of Lucentis Combined With Proton Beam Irradiation in Treating Exudative Age-related Macular Degeneration
Sponsor: Genentech, Inc.
Listed as NCT00517010, this EARLY_PHASE1 trial focuses on Age-related Macular Degeneration and remains completed. Sponsored by Genentech, Inc., it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed Phase 0
First recorded
May 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Genentech, Inc.
- University of California, Davis
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.